Skip to main content
Top
Published in: Diabetologia 7/2009

Open Access 01-07-2009 | Research Letter

Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function

Authors: J. Visser, J. L. Hillebrands, M. Walther Boer, N. A. Bos, J. Rozing

Published in: Diabetologia | Issue 7/2009

Login to get access

Excerpt

To the Editor: Diabetes-prone (DP)-BioBreeding (BB) rats show reduced natural regulatory T cell (nTreg; CD4+/CD25+/forkhead box P3 [FOXP3]+) levels and function, and spontaneously develop type 1 diabetes from 70 days of age [1, 2]. Adoptive transfers of nTregs from diabetes-resistant (DR)-BB rats to DP-BB rats prevents diabetes in DP-BB rats [3, 4]. Environmental factors such as diet are critical triggers for the development of type 1 diabetes [5]. Using the DP-BB rat model for type 1 diabetes, we and others have shown that a hydrolysed casein (HC)-based diet reduces the incidence of diabetes from 90% to 50%, and delays the mean time of diabetes onset [58]. Reduced dietary diabetogenic triggers, skewing of immune responses and induction of islet neogenesis are thought to be the main mechanisms behind the effects of the HC-based diet [58]. …
Literature
1.
go back to reference Mordes JP, Bortell R, Groen H, Guberski DL, Rossini AA, Greiner D (2001) Autoimmune diabetes mellitus in the BB rat. In: Sima AAF, Shafrir E (eds) Animal models for autoimmune diabetes. Harwood Academic, Amsterdam, pp 1–41 Mordes JP, Bortell R, Groen H, Guberski DL, Rossini AA, Greiner D (2001) Autoimmune diabetes mellitus in the BB rat. In: Sima AAF, Shafrir E (eds) Animal models for autoimmune diabetes. Harwood Academic, Amsterdam, pp 1–41
2.
go back to reference Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S (2005) Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174:4081–4089PubMed Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S (2005) Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol 174:4081–4089PubMed
3.
go back to reference Lundsgaard D, Holm TL, Hornum L, Markholst H (2005) In vivo control of diabetogenic T-cells by regulatory CD4+ CD25+ T-cells expressing Foxp3. Diabetes 54:1040–1047PubMedCrossRef Lundsgaard D, Holm TL, Hornum L, Markholst H (2005) In vivo control of diabetogenic T-cells by regulatory CD4+ CD25+ T-cells expressing Foxp3. Diabetes 54:1040–1047PubMedCrossRef
4.
go back to reference Hillebrands JL, Whalen B, Visser JT et al (2006) A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 177:7820–7832PubMed Hillebrands JL, Whalen B, Visser JT et al (2006) A regulatory CD4+ T cell subset in the BB rat model of autoimmune diabetes expresses neither CD25 nor Foxp3. J Immunol 177:7820–7832PubMed
5.
go back to reference Lefebvre DE, Powell KL, Strom A, Scott FW (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26:175–202PubMedCrossRef Lefebvre DE, Powell KL, Strom A, Scott FW (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26:175–202PubMedCrossRef
6.
go back to reference Visser J, Brugman S, Klatter F et al (2003) Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat. Metabolism 52:333–337PubMedCrossRef Visser J, Brugman S, Klatter F et al (2003) Short-term dietary adjustment with a hydrolyzed casein-based diet postpones diabetes development in the diabetes-prone BB rat. Metabolism 52:333–337PubMedCrossRef
7.
go back to reference Brugman S, Klatter FA, Visser J, Bos NA, Elias D, Rozing J (2004) Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47:1331–1333PubMedCrossRef Brugman S, Klatter FA, Visser J, Bos NA, Elias D, Rozing J (2004) Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47:1331–1333PubMedCrossRef
8.
go back to reference Wang GS, Gruber H, Smyth P et al (2000) Hydrolyzed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun 15:407–416PubMedCrossRef Wang GS, Gruber H, Smyth P et al (2000) Hydrolyzed casein diet protects BB rats from developing diabetes by promoting islet neogenesis. J Autoimmun 15:407–416PubMedCrossRef
Metadata
Title
Prevention of diabetes by a hydrolysed casein-based diet in diabetes-prone BioBreeding rats does not involve restoration of the defective natural regulatory T cell function
Authors
J. Visser
J. L. Hillebrands
M. Walther Boer
N. A. Bos
J. Rozing
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1370-3

Other articles of this Issue 7/2009

Diabetologia 7/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.